# IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q1 Balance Sheet

- Company: IDEXX LABORATORIES INC /DE (IDXX)
- Period: As of 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-05, accession number 0000874716-26-000076
- Page: https://plicit.ai/financials/idxx/fy2026-q1-balance-sheet
- Chart image: https://plicit.ai/charts/idxx-fy2026-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 3,385,497,000 US dollars
- **Current assets**: 1,454,075,000 US dollars
- **Non-current assets**: 1,931,422,000 US dollars
- **Liabilities**: 1,829,394,000 US dollars
- **Current liabilities**: 1,299,851,000 US dollars
- **Non-current liabilities**: 529,543,000 US dollars
- **Equity**: 1,556,103,000 US dollars
- **Accounts receivable, net**: 603,544,000 US dollars
- **Inventories**: 382,400,000 US dollars
- **Other current assets**: 267,603,000 US dollars
- **Cash and cash equivalents**: 200,528,000 US dollars
- **Property and equipment, net**: 740,382,000 US dollars
- **Other long-term assets**: 552,791,000 US dollars
- **Goodwill**: 412,104,000 US dollars
- **Operating lease right-of-use assets**: 121,395,000 US dollars
- **Intangible assets, net**: 104,750,000 US dollars
- **Credit facility**: 530,000,000 US dollars
- **Accrued liabilities**: 453,552,000 US dollars
- **Current portion of long-term debt**: 149,997,000 US dollars
- **Accounts payable**: 129,974,000 US dollars
- **Current portion of deferred revenue**: 36,328,000 US dollars
- **Long-term debt, net of current portion**: 299,854,000 US dollars
- **Long-term operating lease liabilities, net of current portion**: 98,747,000 US dollars
- **Other long-term liabilities**: 54,034,000 US dollars
- **Deferred income tax liabilities**: 44,595,000 US dollars
- **Long-term deferred revenue, net of current portion**: 32,313,000 US dollars
- **Retained earnings**: 6,670,348,000 US dollars
- **Additional paid-in capital**: 1,861,079,000 US dollars
- **Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 108,500 shares in 2026 and 108,369 shares in 2025; Outstanding: 79,240 shares in 2026 and 79,712 shares in 2025**: 10,850,000 US dollars
- **Deferred stock units: Outstanding: 60 units in 2026 and 59 units in 2025**: 6,169,000 US dollars
- **Treasury stock, at cost: 29,261 shares in 2026 and 28,657 shares in 2025**: negative 6,927,403,000 US dollars
- **Accumulated other comprehensive loss**: negative 64,940,000 US dollars
- **Gross equity (calculated)**: 8,548,446,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.